A detailed history of Wells Fargo & Company transactions in Asensus Surgical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 46,516 shares of ASXC stock, worth $16,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,516
Previous 44,567 4.37%
Holding current value
$16,280
Previous $10,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.21 - $0.33 $409 - $643
1,949 Added 4.37%
46,516 $15,000
Q1 2024

May 10, 2024

BUY
$0.23 - $0.35 $8 - $12
37 Added 0.08%
44,567 $10,000
Q4 2023

Feb 09, 2024

BUY
$0.21 - $0.36 $5 - $10
28 Added 0.06%
44,530 $14,000
Q3 2023

Nov 13, 2023

SELL
$0.26 - $0.61 $143 - $336
-552 Reduced 1.23%
44,502 $12,000
Q2 2023

Aug 15, 2023

SELL
$0.46 - $0.81 $455 - $801
-990 Reduced 2.15%
45,054 $22,000
Q1 2023

May 12, 2023

BUY
$0.36 - $1.0 $1,781 - $4,948
4,948 Added 12.04%
46,044 $30,000
Q4 2022

Feb 13, 2023

BUY
$0.29 - $0.47 $301 - $488
1,039 Added 2.59%
41,096 $14,000
Q3 2022

Nov 14, 2022

SELL
$0.38 - $0.73 $412 - $792
-1,085 Reduced 2.64%
40,057 $18,000
Q2 2022

Aug 12, 2022

SELL
$0.37 - $0.61 $19,445 - $32,059
-52,556 Reduced 56.09%
41,142 $16,000
Q1 2022

May 16, 2022

SELL
$0.53 - $1.19 $42,987 - $96,519
-81,109 Reduced 46.4%
93,698 $59,000
Q4 2021

Feb 14, 2022

BUY
$1.03 - $2.31 $10,126 - $22,711
9,832 Added 5.96%
174,807 $194,000
Q3 2021

Nov 15, 2021

BUY
$1.74 - $2.93 $275,346 - $463,657
158,245 Added 2351.34%
164,975 $305,000
Q2 2021

Aug 16, 2021

SELL
$1.52 - $3.62 $916 - $2,182
-603 Reduced 8.22%
6,730 $21,000
Q1 2021

May 13, 2021

BUY
$0.9 - $6.32 $6,599 - $46,344
7,333 New
7,333 $24,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.